Latest Insider Transactions at Insmed Inc (INSM)
This section provides a real-time view of insider transactions for Insmed Inc (INSM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INSMED Inc to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INSMED Inc's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 11
2022
|
Carol Schafer Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+31.46%
|
-
|
|
May 11
2022
|
David W J Mcgirr Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+16.79%
|
-
|
|
May 11
2022
|
Leo Lee Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+21.57%
|
-
|
|
May 11
2022
|
Clarissa Desjardins Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+29.15%
|
-
|
|
May 11
2022
|
David R Brennan Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+13.29%
|
-
|
|
May 11
2022
|
Elizabeth M Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+25.71%
|
-
|
|
May 11
2022
|
Alfred Altomari Director |
BUY
Grant, award, or other acquisition
|
Direct |
14,645
+25.34%
|
-
|
|
Mar 23
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
96,614
-11.92%
|
$2,222,122
$23.31 P/Share
|
|
Mar 23
2022
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
96,614
+10.03%
|
$1,449,210
$15.52 P/Share
|
|
Mar 01
2022
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
7,000
-1.0%
|
-
|
|
Mar 01
2022
|
Melvin Md Sharoky Director |
BUY
Bona fide gift
|
Indirect |
2,000
+40.46%
|
-
|
|
Jan 12
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,217
-0.99%
|
$29,208
$24.58 P/Share
|
|
Jan 11
2022
|
Sara Bonstein Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,154
-3.11%
|
$28,850
$25.11 P/Share
|
|
Jan 11
2022
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,495
-3.15%
|
$37,375
$25.11 P/Share
|
|
Jan 11
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
925
-1.6%
|
$23,125
$25.11 P/Share
|
|
Jan 11
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
407
-1.08%
|
$10,175
$25.11 P/Share
|
|
Jan 11
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
2,873
-1.3%
|
$71,825
$25.11 P/Share
|
|
Jan 06
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,458
+14.04%
|
-
|
|
Jan 06
2022
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
9,458
+20.0%
|
-
|
|
Jan 06
2022
|
William Lewis Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
30,741
+12.24%
|
-
|
|
Jan 06
2022
|
Martina M.D. Flammer Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
14,188
+22.99%
|
-
|
|
Jan 06
2022
|
Sara Bonstein Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,006
+25.94%
|
-
|
|
Jan 06
2022
|
Roger Adsett Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,735
+12.59%
|
-
|
|
Jan 06
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
387
-1.35%
|
$10,062
$26.0 P/Share
|
|
Jan 06
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,612
-3.22%
|
$41,912
$26.0 P/Share
|
|
Jan 06
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
5,337
-2.74%
|
$138,762
$26.0 P/Share
|
|
Jan 06
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
1,759
-1.64%
|
$45,734
$26.0 P/Share
|
|
Jan 05
2022
|
Michael Alexander Smith Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
749
-2.54%
|
$20,223
$27.61 P/Share
|
|
Jan 05
2022
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
1,503
-2.92%
|
$40,581
$27.61 P/Share
|
|
Jan 05
2022
|
Martina M.D. Flammer Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
1,423
-4.09%
|
$38,421
$27.61 P/Share
|
|
Jan 05
2022
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
7,126
-3.52%
|
$192,402
$27.61 P/Share
|
|
Jan 05
2022
|
Roger Adsett Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
3,068
-2.78%
|
$82,836
$27.61 P/Share
|
|
Dec 27
2021
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
46,614
-18.73%
|
$1,258,578
$27.72 P/Share
|
|
Dec 27
2021
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
46,614
+15.78%
|
$652,596
$14.24 P/Share
|
|
Dec 23
2021
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
50,000
-10.19%
|
$1,400,000
$28.21 P/Share
|
|
Dec 23
2021
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+8.7%
|
$400,000
$8.82 P/Share
|
|
Nov 19
2021
|
Melvin Md Sharoky Director |
SELL
Bona fide gift
|
Direct |
1,900
-0.8%
|
-
|
|
Nov 01
2021
|
Steinar J Engelsen |
BUY
Open market or private purchase
|
Direct |
14,235
+4.25%
|
$427,050
$30.14 P/Share
|
|
Nov 01
2021
|
David R Brennan Director |
BUY
Open market or private purchase
|
Direct |
10,000
+11.0%
|
$300,000
$30.15 P/Share
|
|
Nov 01
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Open market or private sale
|
Direct |
61,000
-27.28%
|
$1,830,000
$30.68 P/Share
|
|
Nov 01
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
61,000
+35.16%
|
$732,000
$12.44 P/Share
|
|
Sep 30
2021
|
William Lewis Chair and CEO |
SELL
Open market or private sale
|
Direct |
96,614
-17.03%
|
$2,608,578
$27.48 P/Share
|
|
Sep 30
2021
|
William Lewis Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
96,614
+24.43%
|
$289,842
$3.4 P/Share
|
|
Sep 07
2021
|
John Soriano Chief Compliance Officer |
SELL
Open market or private sale
|
Direct |
17,349
-33.01%
|
$485,772
$28.2 P/Share
|
|
Sep 07
2021
|
John Soriano Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
17,349
+24.82%
|
$225,537
$13.91 P/Share
|
|
Jul 08
2021
|
Michael Alexander Smith Chief Legal Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,722
+18.7%
|
-
|
|
May 15
2021
|
William Lewis Chair and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
6,481
-3.12%
|
$168,506
$26.23 P/Share
|
|
May 15
2021
|
Orlov S Nicole Schaeffer Chief People Strategy Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,806
-3.43%
|
$46,956
$26.23 P/Share
|
|
May 15
2021
|
Christine A Pellizzari Chief Legal Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,546
-1.67%
|
$66,196
$26.23 P/Share
|
|
May 15
2021
|
Roger Adsett Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,477
-2.2%
|
$64,402
$26.23 P/Share
|